Nutrien Stock Tumbles 15% as Fertilizer Glut Extends to 2026

Nutrien Ltd. (NTR) shares declined 15% to $48.20 in trading on June 9, 2026. The sell-off followed the company's release of first-quarter earnings, which missed analyst expectations for both revenue and adjusted earnings per share. Management concurrently revised its full-year 2026 guidance downward, citing a prolonged oversupply in global fertilizer markets. The guidance cut confirmed investor fears that the current price-depressing surplus would persist deeper into the decade.

Context — why this matters now

The fertilizer market has struggled with oversupply since the post-2022 price spike, when record-high margins spurred significant capacity expansion. The last comparable multi-year downturn occurred from 2013 to 2016, following a period of rapid Chinese and Belarusian potash capacity additions. That cycle saw the share price of PotashCorp, a Nutrien predecessor, decline approximately 60% from peak to trough before a period of consolidation.

The current macro backdrop features lower agricultural commodity prices and subdued farmer sentiment, reducing immediate demand for crop inputs. Global potash inventories remain elevated above the five-year average, pressuring benchmark prices. The specific catalyst for Nutrien's guidance revision was weaker-than-expected spring application demand in North America, compounded by continued high export volumes from Eastern European producers. This combination eroded the anticipated seasonal price recovery.

Data — what the numbers show

Nutrien reported Q1 2026 revenue of $4.85 billion, a 22% year-over-year decline and $550 million below consensus estimates. Adjusted EBITDA fell 45% to $1.1 billion. The company's adjusted EPS of $1.05 missed the average analyst forecast of $1.42. Management now projects full-year 2026 adjusted EBITDA between $4.8 billion and $5.3 billion, down from prior guidance of $5.5 billion to $6.1 billion.

Nutrien's market capitalization now stands near $24 billion, down from over $55 billion at its 2022 peak. The stock's performance contrasts sharply with the broader market; while the S&P 500 has gained 8% year-to-date, NTR shares have declined 28%. The company's forward price-to-earnings ratio has compressed to 9.5, below its five-year average of 12.3 and the current 16.5 multiple for the materials sector.

Analysis — what it means for markets / sectors / tickers

The sustained fertilizer glut forces a sector-wide pivot from growth spending to capital discipline. This benefits companies with lower-cost production structures, such as Mosaic Co. (MOS), which may gain market share. Conversely, equipment suppliers like Deere & Company (DE) face headwinds as farmer economics tighten and large producers delay expansion projects. The price pressure could shave 3-5% off the expected 2026 earnings for diversified agchem players like Corteva (CTVA).

A key counter-argument is that prolonged low prices will eventually force high-cost producers, particularly some in China and Europe, to shutter capacity, creating a firmer floor for prices. However, this rationalization process may take several more quarters. Institutional positioning data shows hedge funds have increased short exposure across the fertilizer complex, while long-only funds are rotating into downstream food companies. Flow is exiting pure-play producers in favor of companies with more diversified agricultural exposure.

Outlook — what to watch next

The next major catalyst for Nutrien and peers is the Q2 2026 earnings season, starting in late July. These results will confirm the depth of the summer application season slowdown. Investors should monitor weekly potash barge shipments on the Mississippi River, a leading indicator of North American demand. The 50-day moving average near $51.50 now acts as immediate resistance for NTR, with critical support at the 2025 low of $45.10.

The USDA's quarterly Grain Stocks and Acreage report on June 30 will influence crop price forecasts and subsequent fertilizer demand expectations. A key level for the global potash market is the benchmark Brazil CFR price holding above $300 per metric tonne; a break below could trigger another round of producer guidance cuts. The outcome of fall fertilizer negotiations with Chinese buyers, typically concluded by September, will set the tone for 2027 contract pricing.

Frequently Asked Questions

How does Nutrien's dividend look after this guidance cut?

Nutrien's current quarterly dividend of $0.54 per share implies a forward yield of approximately 4.5%. The company has stated its commitment to the dividend, which is supported by strong free cash flow generation even at lower earnings. However, the payout ratio is projected to rise to roughly 65% of adjusted EPS under the new guidance, leaving less buffer for future increases unless earnings recover.

What is the difference between potash and phosphate fertilizer markets?

Potash, primarily potassium chloride, and phosphate fertilizers like DAP have distinct supply dynamics. Potash is more geographically concentrated, with Canada, Russia, and Belarus controlling most reserves. Phosphate production is more global. Currently, both markets face oversupply, but phosphate inventories are rising faster due to new Moroccan and Saudi Arabian capacity, suggesting its price recovery may lag potash's.

Does this affect the stock of CF Industries, which makes nitrogen fertilizer?

Yes, but indirectly. CF Industries Holdings (CF) specializes in nitrogen, which has separate but correlated supply-demand drivers. A prolonged potash price downturn creates overall margin pressure for the agricultural complex and can reduce farmer spending capacity, potentially affecting nitrogen application rates. weak sentiment in one fertilizer segment often spills over to depress valuations across the entire sector.

Bottom Line

Nutrien's guidance cut signals the fertilizer surplus is structural, not cyclical, forcing a multi-year reset of investor expectations for the sector.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.